Updated on 6 January 2014
US FDA raps Chinese clinical trials for ‘sloppy data'
Chinese clinical trials come under the US FDA scanner as the regulator questions the ‘sloppy data generation and irregularities in clinical trial procedures' in the world's most populous country.
ResMed files patent suit against Taiwan's Apex Medical
ResMed files parallel legal actions in the International Trade Commission (ITC) and in US federal court against Taiwanese manufacturer Apex Medical and its US distributor, Medical Depot, alleging that Apex WiZARD 210 and WiZARD 220 masks and APEX iCH and XT Fit flow generators are infringing on its patents.
Nestle enters Chinese medicine market
Nestlé Health Science and Chi-Med form joint venture called Nutrition Science Partners (NSP) in China to focus on gastrointestinal health among others.
Sanofi launches JE vaccine in Australia
IMOJEV is the first single dose vaccine against Japanese encephalitis for adults in Australia.
Indian pharma industry to reach $100 billion
India's Planning Commission also highlighted that Indian pharma will account for five percent of the global drug industry within the next five years and will cross $60 billion mark in 2017.